| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $730M | $549M | $630M | 32.8% | 15.9% |
| Op. Income | $317M | $86M | $251M | 268.1% | 26.6% |
| Gross Margin | 46.9% | 45.5% | 43.4% | 1.4pp | 3.5pp |
| Net Margin | 29.6% | 8.2% | 26.4% | 21.5pp | 3.2pp |
| EPS (Diluted) | $2.37 | $0.49 | $1.80 | 383.7% | 31.7% |
| Free Cash Flow | $60M | -$20M | $80M | 394.7% | -25.3% |
| Item | Amount |
|---|---|
| REVENUE | $730M |
| Cost of Revenue | $387M |
| GROSS PROFIT | $342M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $25M |
| Operating Expenses | $25M |
| Cost & Expenses | $413M |
| OPERATING INCOME | $317M |
| Interest Income | $0 |
| Interest Expense | $45M |
| Other Income/Expenses | -$30M |
| INCOME BEFORE TAX | $288M |
| Income Tax Expense | $71M |
| Net Income from Continuing Ops | $216M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $216M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $216M |
| D&A | $111M |
| EBIT | $332M |
| EBITDA | $444M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $730M |
| Cost of Revenue | $387M |
| GROSS PROFIT | $342M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $25M |
| Operating Expenses | $25M |
| Cost & Expenses | $413M |
| OPERATING INCOME | $317M |
| Interest Income | $0 |
| Interest Expense | $45M |
| Other Income/Expenses | -$30M |
| INCOME BEFORE TAX | $288M |
| Income Tax Expense | $71M |
| Net Income from Continuing Ops | $216M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $216M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $216M |
| D&A | $111M |
| EBIT | $332M |
| EBITDA | $444M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $216M |
| Depreciation & Amortization | $111M |
| Stock-Based Compensation | $6M |
| Deferred Income Tax | $31M |
| Other Non-Cash Items | $10M |
| Change in Working Capital | -$120M |
| OPERATING CASH FLOW | $254M |
| Capital Expenditure | -$194M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $3M |
| NET CASH FROM INVESTING | -$191M |
| Net Debt Issuance | $43M |
| Common Stock Repurchased | -$17M |
| Common Dividends Paid | -$47M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$20M |
| FREE CASH FLOW | $60M |
| Net Change in Cash | $43M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $40M |
| Short-Term Investments | $0 |
| Net Receivables | $370M |
| Inventory | $58M |
| Other Current Assets | $88M |
| TOTAL CURRENT ASSETS | $568M |
| PP&E (Net) | $7.3B |
| Goodwill | $5M |
| Intangible Assets | $0 |
| Long-Term Investments | $72M |
| Tax Assets | $0 |
| Other Non-Current Assets | $487M |
| TOTAL NON-CURRENT ASSETS | $7.9B |
| TOTAL ASSETS | $8.5B |
| Account Payables | $128M |
| Short-Term Debt | $558M |
| Deferred Revenue | $30M |
| Other Current Liabilities | $337M |
| TOTAL CURRENT LIABILITIES | $1.2B |
| Long-Term Debt | $2.4B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $1.1B |
| Other Non-Current Liabilities | $1.1B |
| TOTAL NON-CURRENT LIABILITIES | $4.5B |
| TOTAL LIABILITIES | $5.7B |
| Common Stock | $90M |
| Additional Paid-In Capital | $1.0B |
| Retained Earnings | $1.9B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$223M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.8B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.8B |
| TOTAL LIABILITIES & EQUITY | $8.5B |
| Total Debt | $2.9B |
| Net Debt | $2.9B |
